Atacand and Vesicare drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Atacand (candesartan cilexetil) and Vesicare (solifenacin succinate). Common drug interactions include diverticulum among females and fatigue among males.
The phase IV clinical study analyzes what interactions people have when they take Atacand and Vesicare. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.
What is Atacand?
Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,655 Vesicare users. Check the latest studies of Vesicare.
77 people who take Atacand and Vesicare together, and have interactions are studied.

What are the common drug interactions of Atacand and Vesicare, by gender? *:
female:
- Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
- Emotional disorder
- Fall
- Gastric ulcer (stomach ulcer)
- Haematocrit decreased
- Haemoglobin decreased
- Hepatic failure (liver failure)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Lethargy (tiredness)
- Melaena (the passage of black, tarry stools)
male:
- Fatigue (feeling of tiredness)
- Heart rate decreased
- Ataxia (loss of full control of bodily movements)
- Decreased appetite
- Dysgeusia (disorder of the sense of taste)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Mantle cell lymphoma (cancer of lymphocytes, a type of white blood cell)
- Marrow hyperplasia (increased bone marrow)
- Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
What are the common drug interactions of Atacand and Vesicare, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Death
50-59:
- Alopecia (absence of hair from areas of the body)
- Anaemia (lack of blood)
- Arthropathy
- Asthma
- Ataxia (loss of full control of bodily movements)
- Blood alkaline phosphatase increased
- Breast mass
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
- Bunion (a painful swelling on the first joint of the big toe)
60+:
- Muscle spasms (muscle contraction)
- Oedema peripheral (superficial swelling)
- Asthenia (weakness)
- Dry mouth
- Dyspnoea (difficult or laboured respiration)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperkalaemia (damage to or disease of the kidney)
- Chest pain
- Carotid artery disease
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
What are the existing conditions these people have? *
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 12.99%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 8 people, 10.39%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 9.09%
- Pain: 7 people, 9.09%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 7.79%
- Depression: 6 people, 7.79%
- High Blood Cholesterol: 6 people, 7.79%
- Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 5 people, 6.49%
- Diabetes: 5 people, 6.49%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 6.49%
* Approximation only. Some reports may have incomplete information.
Do you take Atacand and Vesicare?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Atacand and Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Atacand:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atacand and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on candesartan cilexetil and solifenacin succinate (the active ingredients of Atacand and Vesicare, respectively), and Atacand and Vesicare (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Diphen and Pancreaze - now
- Could Naltrexone Hydrochloride cause Respiratory Tract Infection? - 4 seconds ago
- Could Fentanyl cause Immunodeficiency Disorders? - 7 seconds ago
- Lamotrigine and Weight Gain - Unintentional for Girls aged 10-19 - 10 seconds ago
- Lamotrigine and Weight Gain for Girls aged 10-19 - 10 seconds ago
- Lamotrigine and Weight Increased for Girls aged 10-19 - 11 seconds ago
- Could Prolia cause Urinary Tract Obstruction? - 16 seconds ago
- Drug interactions of Butrans and Lopurin - 21 seconds ago
- Hiatal Hernia and drugs of ingredients of vortioxetine - 25 seconds ago
- Could Oxycodone Hydrochloride cause Decreased Interest? - 26 seconds ago